This website uses cookies to help us give you the best experience when you visit our website. By continuing to use this website, you consent to our use of these cookies.

Find out more about how we use cookies and how to manage them by reading our cookie notice.

Posted 09 Oct 2015

Targeting escape pathways to further personalise breast cancer treatment

About the author

Dr Asud Khaliq

Dr Asud Khaliq

View author

Other articles from this author

Follow AstraZeneca: